Elliott Bennett-Guerrero, MD, has served as a professor and vice chairman at Stony Brook Medicine since 2015. He also functions in the role of medical director for perioperative quality and patient safety. Recently, Elliott Bennett-Guerrero has focused on treating patients who are in intensive care due to COVID-19.
In this position he has taken the lead on an important research project designed to determine whether or not convalescent blood plasma taken from recovered patients can provide a critical immune system boost to patients fighting severe, life-threatening COVID infections. Plasma therapy has a long medical history. It was first used during the 1890s during outbreaks of influenza, measles, and mumps. Put simply, blood plasma taken from healthy patients contains antibodies that have been specifically created to fight off a target infection. By introducing COVID-19 antibodies into the systems of patients still fighting the infection, this therapy aims to block adverse effects of the virus in the body in the early phase of illness before the patient can begin producing their own antibodies against the virus. The initial call was for 500 patients, with 80 percent set to receive the treatment at the North Shore University Medical Center and Long Island Jewish Medical Center. However, the study may expand to other facilities and ultimately involve thousands of patients.
0 Comments
|
AuthorDr. Elliott Bennett-Guerrero is both an educator and a vice chairman at Stony Brook Medicine. Archives
June 2022
Categories
All
|